Translate
Fortress Biotech Inc
About
Fortress Biotech Inc (NASDAQ:FBIO) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
Mar 30 2026
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
Mar 25 2026
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Mar 18 2026
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
Feb 23 2026
UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Recent Videos
Fortress Biotech, Inc. (0001429260) (Filer) #Shorts
Apr 04, 2026
Fortress Biotech: My Take on Their 2025 Strategy & Risks
Apr 04, 2026
3 Micro-Cap Biotech Catalysts Coming in 2026—Which Has Real Upside?
Jan 24, 2026
FBIO STOCK : READY FOR RECOVERY | FORTRESS BIOTECH STOCK
Jan 17, 2026
Financials
Revenue
$63.26 M
Market Cap
$81.55 M
EPS
-0.07